Clariane SE (CLARI) Earnings Call Transcripts

Clariane SE's Latest Earnings Call - Q1 FY2026

Clariane SE reported its first quarter 2026 earnings, highlighting a solid organic revenue growth of 4.9%, aligning with its trajectory. Revenue reached EUR 1.336 billion, a 1.4% increase year-over-year. The company reiterated its guidance for 2026, maintaining a target of around 5% organic revenue CAGR and an EBITDA margin improvement of 100 to 150 basis points compared to 2023. Management confirmed a successful EUR 500 million bond issuance, strengthening liquidity and refinancing upcoming maturities.

Reported metrics

Guidance from management

Clariane maintained its guidance for 2026, expecting around 5% organic revenue growth and an EBITDA margin improvement of 100 to 150 basis points compared to 2023. Financial leverage is projected to be below 5x by the end of 2026.

What management said

Okay. Gregory, from the web, we have a few questions regarding the capital structures, more specifically regarding the hybrids. So how should we think about the capital strategy for the group, especially regarding your capital instrument, i.e., the GBP and the ODIRNANE? How are you going to deal with those bonds? Are you going to repay them in the next 12 to 18 months?

Thank you, Gregory. On the operational side, a few questions, the first one, at what level do you think occupancy could peak for the company versus the 91.7% of the moment? Is 95% achievable, and if so, how quickly?

What analysts pressed on

Analysts questioned the capital strategy, particularly regarding hybrid instruments and their refinancing. Concerns were also raised about the speed of occupancy rate improvements in France and the impact of energy costs due to geopolitical tensions.

Main topics on the call

• Organic Revenue Growth — Clariane achieved a 4.9% organic revenue growth, driven by improvements in occupancy and pricing across its segments, with long-term care showing a 5.5% growth. 'This performance is supported by both volume and pricing e...
• Debt Refinancing — The company issued a EUR 500 million high-yield bond, oversubscribed by 5x, to refinance upcoming maturities, enhancing liquidity. 'This transaction was very well received by investors.'
• Occupancy Rates — Occupancy rates improved to 91.7%, with potential to reach 94-95% as a group target. 'We still have further growth potential embedded within our existing capacity.'
• Energy Cost Management — Clariane has hedged 98% of its 2026 energy needs, minimizing exposure to volatility. 'We have also significant coverage for 2027 and 2028.'

Read the full Clariane SE transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 18 Clariane SE earnings call transcripts on record, spanning February 28, 2020 to July 30, 2026. Based on this history, Clariane SE reports semi-annually. The most recent call on file is dated July 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

CLARI

Exchange

ENXTPA

Country

FR

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

18

First call

February 28, 2020

Most recent

July 30, 2026

Reporting cadence

semi-annually